Summary For May 2026
Portfolio @ End of May26
May 2026 was a special month to my portfolio, represented by big rise in some stocks and big slump in some.
MI jumped 45%, JHM & Kobay both advanced 28% and 25% respectively.
Meanwhile, EUPE & MMSV both fell around 13%. Hiaptek, Hibiscus, Teoseng and TMCLife all dropped 8%.
Overall, my portfolio still able to close the month with a small gain of 1.3%, lifting the YTD gain to 12%.
Summary of February 2026
Portfolio @ End of Feb26
Following a spectacular start to the year, Feb26 was not a good month for KLCI as it dropped 1.4%, bringing down the YTD gain to 2.2%.
My portfolio also lost 0.5% in the month, in which both JHM & MMSV suffered 19% & 16% drop respectively after posting bad quarter results.
I have made a calculation error in my Jan26 portfolio gain and I've made the correction. The gain should be 9.13%, not 11% as posted earlier.
Anyway, the Middle East is at war now and the world stock markets generally tumbled.
Summary For May 2025
Portfolio @ End of May25
In May25, my portfolio gained 1.5% thanks to KFIMA & FOCUSP.
However, YTD it still suffers 8% loss, matching KLCI's lackluster performance.
I decided to reduce my shares in TAS, even though it's expected to deliver a decent result next quarter.
FOCUSP's FY25Q1's revenue and PAT both improved YoY to RM72.9mil & RM7.9mil (EPS 1.71sen) which is good. There was RM0.7mil of inventories written down/off in the quarter.
Anyway, its F&B segment swung back into loss which is a slight disappointment.
A 1.75sen interim dividend was declared, as expected and similar to last year.
Summary For May 2024
Portfolio @ End of May24
May24 is not a bad month for me. Even though previous "heavyweights" EUPE & TAS fell 14% and 3.3% respectively, latest heavyweight stock Fajar climbed 38.5%.
I manage to buy more Fajar's shares at average price of 35sen before it released its FY24Q3 result.
As a result, my portfolio was able to gain 3.15% in the month, lifting overall YTD gain to 32.7%.
KLCI's YTD gain has almost reached 10% which is undoubtedly its best performance in more than 10 years.
Summary For March 2024
Portfolio @ End of Mac24
In Mac24, the two newly added stocks ADB & EUPE performed brightly as they rose 37.6% and 9.3% respectively.
This has helped to propel my portfolio to gain 1.6% in Mac24. YTD gain improves slightly to 8.1%.
The share price of ADB inched up almost everyday and I have no chance to add more shares. Thus it only contributes rather minimally to my portfolio despite appreciated 35%.
Meanwhile, the share price of EUPE took a break below RM1 so I took this opportunity to buy more of its shares, with a target price of RM2.
Summary For November 2023
Portfolio @ End of Nov23
In November 2023, my portfolio value inched up 0.8%. YTD gain is still below 10%.
Gtronic's share price moved up the most by 12.6% in the month, and now we know why.
Gtronic's founder will dispose his entire 10.4% shares to APB Resources Bhd at a price of RM2.00 per share.
To me, this is not an exciting news as it's not good to see any founder exiting his own company.
Furthermore, the buyer APB seems to be in oil & gas fabrication industry and I'm not sure whether it can bring growth to Gtronic.
Summary For November 2022
My Portfolio @ End of Nov22
In the month of Nov22, tech-related stocks staged a good rebound. MI & Gtronic both rose 13.7% & 10.6% respectively but JHM dropped 11.6%.
The downtrend of JHM continues and it has already lost 25% in two months.
Meanwhile, the share price of Krono and Uchitec stay relatively flat.
MyNews is the top performer in my portfolio this month with a 15.9% gain, followed closely by Hibiscus at 14.4% gain.
Overall, Nov22 was dominated by General Election 15 and it was a good month for Malaysia's stock market.
The outcome of the election with the resulting "Unity Government" seems to be welcomed by most investors.
Summary of August 2022
In August 2022, MI suffered a meltdown and lost 22% in one month's time. However, my portfolio still manage to register a monthly gain of 3.7% thanks to Hibiscus, myNews and Uchitec.
Hibiscus's FY22Q4's result was very good as expected, with a PATAMI of RM215.5mil (EPS 10.7sen).
As a result, its share price rallied from 80sen+ to over RM1.00. The drop of Brent oil below USD100 and the tax dispute with Sabah government might have prevented its share price to re-visit RM1.50 level.
Its cash flow is generally OK and I think it should be able to achieve at least 20sen of EPS in FY23 even if the Brent oil falls to USD70-80.
For those companies in my portfolio, I think the latest quarterly results of Uchitec, MFCB, Rhonema, JHM, Master and LEESK are good.
The rest are so-so.
Summary For November 2021
Portfolio @ End of Nov21
In November my portfolio suffered 12.6% loss which matched previous heaviest monthly loss in Oct18, apart from a 21.7% Covid-driven slump in Mac20.
The share prices of all 17 stocks dropped in this month. Even in Mac20 rout there was still one stock in my portfolio that stood tall and did not drop, which was Daya at 0.5sen per share. Haha.
KLCI dropped non-stop all the way from 1,600 points in mid October to settle at 1,514 points at the end of November.
The sentiment in Malaysia's stock market started to turn sour after the announcement of Budget 2022.
The drastic drop came in the final few days of November when new variant of Covid-19 Omicron emerged as a "Variant of Concern".
Brent oil price dived USD10 or 12% from USD82 to USD72 in just one day.
After its 80%-owned 260MW Don Sahong hydroelectric dam in Laos started operation in 2020, we know for sure that MFCB is becoming and will become a cash cow.
The concession period for the dam is 25 years which is up to 30th September 2045.
From the most recent FY21Q2 quarter report, the 6-months PBT from its renewable energy segment is RM176.8mil which is almost entirely from Don Sahong with negligible contribution from its solar business.
With the second half of the year expected to contribute more, it's safe to estimate a PBT of RM400mil per year from Don Sahong.
As depreciation and amortization are usually huge for such infrastructure, I guess the operating cash flow from it might be around or even more than RM400mil per year.
What will you do if your company has RM400mil cash coming in consistently every year?
Summary For August 21
Stock Portfolio @ End of Aug21
In August 2021, Malaysia has a change of government again. The stock market viewed it quite positively in which the KLCI gained 100 points (~7%) from 1,500 to 1,600.
In the same month, our Covid-19 vaccination rate continued to be encouraging but new Covid-19 cases soared and stayed above 20,000 cases per day.
As of today, it's reported that over 65% of adults population are FULLY vaccinated.
Even though we're not sure whether the vaccines can successfully fence off the virus mutants, we should be able to achieve 80% adult vaccination mark at the end of this month.
Stock market wise, my monthly portfolio return of 3% was beaten by KLCI's 7% gain.
Summary For May 2021
Portfolio @ End of May21
Due to the slump in SCIB share price, my portfolio suffers its heaviest loss in one month at -19% since losing 21.7% in Mac20.
SCIB was my major holding and made up ~40% of my portfolio. It has contributed massively to my portfolio gain this year but now I have to vomit out those gain.
The big news in the stock market in May should be none other than Serba Dinamik's audit issue.
Serbadk first announced its intention to appoint an independent firm to commence a special independent review on its accounting matters raised by external auditor KPMG on 25th May 2021.
It's then followed by a public holiday, 2 days of trading suspension and 2 days of weekend.
When trading resumed on the 31 May, its share price straight away limited down.
